Cidara Therapeutics Inc Cash Flow Quality Index
Cidara Therapeutics Inc cash flow quality index. Cidara Therapeutics Inc (CDTX) has a Cash Flow Quality Index of -3.62x as of March 2023. Operating cash flow of $-10.90 Million is below net income of $3.01 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Cidara Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cidara Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Cidara Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Cidara Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Cidara Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|